Succinylcholine Contraindications and Safety Considerations

Contraindications

Succinylcholine is contraindicated in patients with primary muscle damage or up-regulation of nicotinic acetylcholine receptors at the motor end plate, as it can induce generalized contraction with rhabdomyolysis 1
In patients with specific muscle disorders, such as myopathy or myotonia, succinylcholine can cause life-threatening hyperkalemia 1, 2
Succinylcholine is specifically contraindicated in patients with Duchenne muscular dystrophy due to risk of acute rhabdomyolysis, hyperkalemia, and cardiac arrest 3

Standard adult dosing for intubation is typically 1.0 mg/kg (real weight) 4
Age-appropriate doses for children have been established: < 1 month: 1.8 mg/kg, > 1 month and < 1 year: 2.0 mg/kg, > 1 year and < 10 years: 1.2 mg/kg, > 10 years: 1.0 mg/kg 5
In the presence of pretreatment with pyridostigmine or under the effects of nerve agent poisoning, the amount of succinylcholine needed for sufficient muscle relaxation should be reduced significantly 6

Quantitative neuromuscular monitoring is essential when administering neuromuscular blocking drugs, including succinylcholine 7
Clinical tests of recovery are inadequate for assessing recovery from neuromuscular blockade 7
Every operating theater where neuromuscular blocking drugs are used should be equipped with a quantitative neuromuscular monitoring device 7

In cases where succinylcholine is contraindicated, rocuronium at doses slightly above the normal intubation dosage may be preferred due to its mild vagolytic effect and lack of acetylcholinesterase-dependent metabolism 6
For rapid sequence induction in children where succinylcholine is contraindicated, rocuronium is recommended as an alternative 5

In patients with nerve agent intoxication, it is recommended to abstain from using succinylcholine due to potential interactions with acetylcholinesterase inhibitors 6, 8